Beta Bionics, Inc. BBNX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.89% | -62.59% | 5.23% | 15.77% | 41.13% |
| Total Depreciation and Amortization | 13.27% | 5.56% | 36.90% | 4.59% | 8.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.16% | 0.92% | 17.01% | 8.71% | -71.68% |
| Change in Net Operating Assets | 106.25% | -513.90% | -522.08% | 121.15% | 76.84% |
| Cash from Operations | 38.65% | -176.25% | 1.17% | 35.79% | 31.94% |
| Capital Expenditure | 24.55% | 27.64% | -48.44% | 27.94% | -434.23% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.49% | 806.52% | -76.22% | 35.41% | 104.45% |
| Cash from Investing | 23.33% | 3,219.00% | -93.06% | 53.67% | 103.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 189.09% | -41.23% | -60.05% | 6,216.67% | -99.98% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 189.09% | -41.23% | -60.05% | 6,216.67% | -99.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,130.07% | 80.17% | -302.61% | 146.21% | -161.38% |